Brenda J. Crowe

发表

Program Safety Analysis Plan: An Implementation Guide

Wei Wang, Qi Jiang, H. Amy Xia, 2014 .

Clinical Trial Drug Safety Assessment With Interactive Visual Analytics

Wei Wang, Brenda J. Crowe, Mary E. Nilsson, 2020 .

Meta-analysis of clinical trial safety data in a drug development program: Answers to frequently asked questions

Jesse A. Berlin, H. Amy Xia, Brenda J. Crowe, 2013, Clinical trials.

The Use of Metaanalysis in Pharmacoepidemiology

Brenda J. Crowe, S. Evans, J. Berlin, 2019, Pharmacoepidemiology.

Clinical Trial Drug Safety Assessment for Studies and Submissions Impacted by COVID-19

Brenda J. Crowe, G. Ball, S. Shahin, 2020, Statistics in biopharmaceutical research.

A Pulmonary Fibrosis Research Contact Registry

Brenda J. Crowe, F. Wamboldt, J. Swigris, 2014 .

Protocol for a mixed-methods study of supplemental oxygen in pulmonary fibrosis

Brenda J. Crowe, E. Root, K. Albright, 2014, BMC Pulmonary Medicine.

Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial.

Brenda J. Crowe, M. Geffner, J. Ross, 2007, The Journal of clinical endocrinology and metabolism.

Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial.

Brenda J. Crowe, J. Troendle, J. Baron, 2004, The Journal of clinical endocrinology and metabolism.

Trial with Idiopathic Short Stature: A Randomized, Double-Blind, Placebo-Controlled Effect of Growth Hormone Treatment on Adult Height in Peripubertal Children

Brenda J. Crowe, J. Troendle, J. Yanovski, 2004 .

Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.

Brenda J. Crowe, C. Quigley, J. Chipman, 2002, The Journal of clinical endocrinology and metabolism.

Current Practices, Challenges, and Statistical Issues With Product Safety Labeling

Brenda J. Crowe, P. Kulkarni, C. Beasley, 2013 .

Safety of growth hormone treatment in pediatric patients with idiopathic short stature.

Brenda J. Crowe, J. Wit, F. Cassorla, 2005, The Journal of clinical endocrinology and metabolism.

Effect of growth hormone dose on bone maturation and puberty in children with idiopathic short stature.

Brenda J. Crowe, J. Wit, A. Wolka, 2006, The Journal of clinical endocrinology and metabolism.

Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency

Brenda J. Crowe, G. Rappold, B. Niesler, 2006, Journal of Medical Genetics.

Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status--3-year results from the HypoCCS Database.

Brenda J. Crowe, R. Bouillon, C. Strasburger, 2002, The Journal of clinical endocrinology and metabolism.

The FDA's Final Rule on Expedited Safety Reporting: Statistical Considerations

Brenda J. Crowe, J. Wittes, Qi Jiang, 2015, Statistics in biopharmaceutical research.

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial

Brenda J. Crowe, D. Enikeev, S. de Bono, 2021, The Lancet Respiratory Medicine.

The phenotype of short stature homeobox gene (SHOX) deficiency in childhood: contrasting children with Leri-Weill dyschondrosteosis and Turner syndrome.

Brenda J. Crowe, A. Zinn, J. Ross, 2005, The Journal of pediatrics.

Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial.

Brenda J. Crowe, G. Rappold, D. Cao, 2007, The Journal of clinical endocrinology and metabolism.

Psychological adaptation in children with idiopathic short stature treated with growth hormone or placebo.

Brenda J. Crowe, J. Baron, F. Cassorla, 2004, The Journal of clinical endocrinology and metabolism.

Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect.

Brenda J. Crowe, J. Wit, J. Chaussain, 2005, The Journal of pediatrics.

Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency?

Brenda J. Crowe, D. Clemmons, K. Ho, 2002, The Journal of clinical endocrinology and metabolism.

Seeing is believing: good graphic design principles for medical research

Taxiarchis Botsis, Mat Soukup, Richard Forshee, 2015, Statistics in medicine.

Prospective Safety Surveillance of GH-Deficient Adults: Comparison of GH-Treated vs Untreated Patients

Brenda J. Crowe, L. Robison, S. Melmed, 2013, The Journal of clinical endocrinology and metabolism.

Reference Limits for Outlier Analyses in Randomized Clinical Trials

Brenda J. Crowe, R. Dean, P. S. Horn, 2017, Therapeutic innovation & regulatory science.

The Evaluation of Adverse Events in Clinical Trials (with a Particular Focus on the Use of Meta-Analysis)

Brenda J. Crowe, J. Berlin, H. A. Xia, 2014 .

Recommendations for safety planning, data collection, evaluation and reporting during drug, biologic and vaccine development: a report of the safety planning, evaluation, and reporting team

Jesse A Berlin, Devan V Mehrotra, H Amy Xia, 2009, Clinical trials.

Comparison of Bayesian and Frequentist Meta-Analytical Approaches for Analyzing Time to Event Data

John W Seaman, James D Stamey, Karen L Price, 2013, Journal of biopharmaceutical statistics.

Ralph haploinsufficiency stature : clinical indicators of SHOX Genotypes and phenotypes in children with short

Brenda J. Crowe, G. Rappold, B. Niesler, 2006 .

Efficacy and safety of baricitinib in patients with COVID-19 infection: Results from the randomised, double-blind, placebo-controlled, parallel-group COV-BARRIER phase 3 trial

Brenda J. Crowe, D. Adams, E. Ely, 2021 .

Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways

Brenda J. Crowe, R. Higgs, M. Petri, 2020, Lupus science & medicine.

Adaptation of the robust method to large distributions of reference values: program modifications and comparison of alternative computational methods

Brenda J. Crowe, R. Dean, P. S. Horn, 2019, Journal of biopharmaceutical statistics.

Baricitinib plus Standard of Care for Hospitalized Adults with COVID-19

Brenda J. Crowe, S. de Bono, V. Marconi, 2021, medRxiv.

Robust Behavior Cloning with Adversarial Demonstration Detection

Brenda J. Crowe, Marek Petrik, Mostafa Hussein, 2021, 2021 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS).

Planning and core analyses for periodic aggregate safety data reviews

H Amy Xia, Brenda J. Crowe, Brenda J Crowe, 2011, Clinical trials.